Gudmund Tyge Korsgaard

NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.

MAJ Invest Equity A/S (MAJ Invest) is a private equity subsidiary of Fondsmæglerselskabet MAJ Invest A/S, itself a subsidiary of MAJ Invest Holding A/S. The firm was founded in 2005 and is headquartered in Copenhagen, Denmark.

Fondsmæglerselskabet Maj Invest A/S (FM Invest) is the wholly-owned asset management subsidiary of Maj Invest Holding A/S in Denmark. The firm was founded in 2005 and is headquartered in Copenhagen. FM Invest provides advice on strategic asset allocation and asset management of securities listed on regulated markets for institutional clients and serves as the investment adviser to the Maj Invest mutual funds in Denmark and Luxembourg, which are owned by their members. They also offer wealth management services to wealthy individuals, companies and funds.

Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark.

CAPRES A/S develops, manufactures, and sells micro-scale electromechanical components and systems. It specializes in technology that allows direct measurement of sheet resistance, Hall Mobility, and Active Carrier Density. The company was founded by Peter Folmer Nielsen, Christian Leth Petersen, and Ulrik Quade in 1999 and is headquartered in Kongens Lyngby, Denmark.

TD Vaccines A/S S is a holding company that focuses on the development of vaccines to protect against travellers' diarrhoea (TD). It is a biotechnology company that discovers and develops novel vaccines to fight serious bacterial infections. Its lead programme is ACE527, an oral ETEC vaccine to protect against ETEC (Enterotoxigenic E Coli). Its oral combination vaccine, ACE920, designs to protect against ETEC and Campylobacter infections. The company was founded in November 2009 and is headquartered in Skorping, Denmark.

Den Sociale Kapitalfond Invest I K/S is a social impact fund investing in small and mid-size companies located in Denmark and Sweden. The fund targets companies operating in industries such as manufacturing, consumer durables and services, and with annual revenues of DKK 30 to 200 million. It provides financing for growth-stage capital requirements, and makes co-investments. The fund looks to take minority stake positions, and a seat on the board.